Henan Taloph Pharmaceutical Stock Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Henan Tailong Pharmaceutical Co., Ltd. was founded in 1993, mainly engaged in drug manufacturing and drug research and development services, including four business segments: drug preparations, traditional Chinese medicine decoction pieces, drug research and development services, and drug and medicinal material circulation. The main products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, Xiao'er Qingre Zhike oral liquid, Xiao'er Compound Chicken Neijin Chewing Tablets, Huperzine A tablets, etc. Among them, Shuanghuanglian Oral Liquid (concentrated type), Shuanghuanglian Oral Liquid (children's type), Shuangjinlian Mixture, and Children's Compound Chicken Inner Gold Chewing Tablets are the exclusive products of the company. In 1999, Tai Long Pharmaceutical's stock was grandly listed on the Shanghai Stock Exchange, becoming the first listed company in the pharmaceutical industry in Henan Province. After more than 20 years of development, Tai Long Pharmaceutical has indirectly participated in and controlled more than ten subsidiaries (branches), covering fields such as pharmaceutical manufacturing, drug research and development, and capital operation. Its main economic indicators are among the top in the pharmaceutical industry in Henan Province. |
| Headquarter | Zhengzhou |
| Establish Date | 8/31/1998 |
| Listed Code | 600222.SH |
| Listed Date | 11/5/1999 |
| Chairman | Yin Hui. |
| CEO | Li Jingliang. |
| Website | www.taloph.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
